Clinical trial
Pharmacogenetics of Gastrointestinal Bleeding
NCT00190255 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00190255 |
|---|---|
| Title | Pharmacogenetics of Gastrointestinal Bleeding |
| Official title | Pharmacogenetics of Gastrointestinal Bleeding Under Nonsteroidal Anti-inflammatory Drugs : the Role of Cytochrome P450 2C9 |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Gastrointestinal Hemorrhage, Stomach Ulcer, Non-steroidal Anti-inflammatory Drug Sensitivity |
| Intervention type | Procedure |
| Interventions | CY2PC9 genotyping |
| Enrollment | 200 |
| Start date | Apr 1, 2004 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Sep 19, 2005 |
| Last update posted | May 10, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: